AR
ARCH Venture
Chicago ILFounded 198640 employees
Private CapbiotechPrivateOncology
Platform: Biotech VC
Market Cap
N/A
All Drugs
3
Clinical Trials
6
Failed / Terminated
0
FDA Approved
1
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| ARC-5137 | ARC-5137 | Approved | 4 | IL-23 | SCD | ||
| Mirirelsin | ARC-4729 | Phase 1/2 | 1 | GPRC5D | ET | ||
| ARC-6205 | ARC-6205 | NDA/BLA | 1 | FLT3 | PTSD |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (5)